Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis

Biomarkers

Volumn 17, Issue 1, 2012, Pages 16-20

  Huang, Ke ^a   Du, Gang ^a   Li, Lin ^a   Liang, Hongsuo ^a   Zhang, Bo ^a  

^a The Third Affiliated Hospital of Guangxi Medical University The Second Nanning People s Hospital   (China)

Author keywords

Chemerin; Osteoarthritis; Severity; Synovial fluid

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CHEMERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN BLOOD LEVEL; SYNOVIAL FLUID LEVEL;

AGED; CASE-CONTROL STUDIES; CHEMOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 84863012616     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.634028     Document Type: Article

References (28)

1. Berg V, Sveinbjörnsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y. (2010). Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes infammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ter 12:R228.
2. Blagojevic M, Jinks C, Jefery A, Jordan KP. (2010). Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr Cartil 18:24-33.
3. Chen WP, Bao JP, Feng J, Hu PF, Shi ZL, Wu LD. (2010). Increased serum concentrations of visfatin and its production by diferent joint tissues in patients with osteoarthritis. Clin Chem Lab Med 48:1141-1145.
4. Cheng T, Li FF, Zhao S, Peng XC, Zhang XL. (2010). Soluble P selectin in synovial fuid level is correlated with the radiographic severity of knee osteoarthritis. Clin Chim Acta 411:1529-1531.
5. Choe JY, Bae J, Jung HY, Park SH, Lee HJ, Kim SK. (2011). Serum resistin level is associated with radiographic changes in hand osteoarthritis: Cross-sectional study. Joint Bone Spine. (In Press). DOI: 10.1016/j.jbspin.2011. 04.009.
6. Clements DN, Carter SD, Innes JF, Ollier WE, Day PJ. (2006). Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction. Arthritis Res Ter 8:R158.
7. Conde J, Gomez R, Bianco G, Scotece M, Lear P, Dieguez C, Gomez-Reino J, Lago F, Gualillo O. (2011). Expanding the adipokine network in cartilage: identifcation and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70:551-559.
8. Conrozier T, Carlier MC, Mathieu P, Colson F, Debard AL, Richard S, Favret H, Bienvenu J, Vignon E. (2000). Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 59: 828-831.
9. Dong B, Ji W, Zhang Y. (2011). Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50:1093-1097.
10. El-Arman MM, El-Fayoumi G, El-Shal E, El-Boghdady I, El-Ghaweet A. (2010). Aggrecan and cartilage oligomeric matrix protein in serum and synovial fuid of patients with knee osteoarthritis. HSS J 6:171-176.
11. Ellabban AS, Kamel SR, Ahmed SS, Osman AM. (2011). Receptor activator of nuclear factor kappa B ligand serum and synovial fuid level. A comparative study between rheumatoid arthritis and osteoarthritis. Rheumatol Int. (In Press). DOI: 10.1007/s00296-011-1831-0.
12. Garnero P, Mazières B, Guéguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M. (2005). Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 32:697-703. (Pubitemid 40524704)
13. Honsawek S, Chayanupatkul M. (2010). Correlation of plasma and synovial fuid adiponectin with knee osteoarthritis severity. Arch Med Res 41:593-598.
14. Hu PF, Tang JL, Chen WP, Bao JP, Wu LD. (2011). Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients. Int Orthop 35:1421-1426.
15. Hu W, Feng P. (2011). Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 91:159-163.
16. Iannone F, Lapadula G. (2003). Te pathophysiology of osteoarthritis. Aging Clin Exp Res 15:364-372.
17. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. (2011). Role of proinfammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7:33-42.
18. Kellgren JH, Lawrence JS. (1957). Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502.
19. Ku JH, Lee CK, Joo BS, An BM, Choi SH, Wang TH, Cho HL. (2009). Correlation of synovial fuid leptin concentrations with the severity of osteoarthritis. Clin Rheumatol 28:1431-1435.
20. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C, Göke B, Leber AW, Parhofer KG, Broedl UC. (2009). Chemerin is associated with markers of infammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161:339-344.
21. Li X, Ellman M, Muddasani P, Wang JH, Cs-Szabo G, van Wijnen AJ, Im HJ. (2009). Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum 60:513-523.
22. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, John H, Richter R, Schleuder D, Meyer M, Forssmann WG. (2003). Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett 555:495-499. (Pubitemid 37532599)
23. Orita S, Koshi T, Mitsuka T, Miyagi M, Inoue G, Arai G, Ishikawa T, Hanaoka E, Yamashita K, Yamashita M, Eguchi Y, Toyone T, Takahashi K, Ohtori S. (2011). Associations between proinfammatory cytokines in the synovial fuid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee. BMC Musculoskelet Disord 12:144.
24. Pierzchala AW, Kusz DJ, Hajduk G. (2011). CXCL8 and CCL5 expression in synovial fuid and blood serum in patients with osteoarthritis of the knee. Arch Immunol Ter Exp (Warsz) 59:151-155.
25. Stürmer T, Brenner H, Koenig W, Günther KP. (2004). Severity and extent of osteoarthritis and low grade systemic infammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 63:200-205.
26. Yamamoto T, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Axelsson J. (2010). Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 25:4017-4023.
27. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schäfer A, Aslanidis C, Schölmerich J, Buechler C. (2010). Systemic chemerin is related to infammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 72:342-348.
28. Wolfe F. (1997). Te C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 24: 1486-1488. (Pubitemid 27320686)